IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY

Morphological manifestations of prostate cancer (PCa) in 15–20% of cases are similar to those with benign hyperplastic processes in prostate tissue and/or with a histological pattern of atypical small acinar proliferation (ASAP).The purpose of this study is a comparative study of the detection of pr...

Full description

Bibliographic Details
Main Authors: S. V. Popov, R. G. Guseynov, O. N. Skryabin, I. N. Orlov, A. A. Vorobyov, A. G. Martov, V. L. Shchukin
Format: Article
Language:Russian
Published: QUASAR, LLC 2019-04-01
Series:Issledovaniâ i Praktika v Medicine
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/356
_version_ 1797874079055740928
author S. V. Popov
R. G. Guseynov
O. N. Skryabin
I. N. Orlov
A. A. Vorobyov
A. G. Martov
V. L. Shchukin
author_facet S. V. Popov
R. G. Guseynov
O. N. Skryabin
I. N. Orlov
A. A. Vorobyov
A. G. Martov
V. L. Shchukin
author_sort S. V. Popov
collection DOAJ
description Morphological manifestations of prostate cancer (PCa) in 15–20% of cases are similar to those with benign hyperplastic processes in prostate tissue and/or with a histological pattern of atypical small acinar proliferation (ASAP).The purpose of this study is a comparative study of the detection of prostate cancer in biopsy material using a review morphological analysis and immunohistochemistry with the use of monoclonal antibodies to the nuclear p63 protein, high molecular weight cytokeratins of clone 34βE12 and α-methylacyl-CoA-racemase.Materials and methods. The method of the study was a retrospective analysis of the findings on the review morpholog­ical and immunohistochemical (IHC) analyzes of biopsy material of 428 patients who were examined and treated in the urological hospital for the period from 2013 to 2017.Results. Almost half of the cases of ASAP, determined by routine histological examination of biopsy specimens with hematoxylin-eosin staining, in the process of IHC analysis using monoclonal antibodies to the nuclear protein p63, cyto­keratins of clone 34βE12 and α-methylacyl-CoA racemase were verified for prostate cancer. The number of histological findings on benign prostatic hyperplasia detected in routinely stained preparations decreased by 12.38% in favor of the histological diagnosis of prostate cancer after the IHC study.Conclusion. Immunohistochemical analysis of biopsy material using monoclonal antibodies to nuclear p63, high-molec­ular cytokeratins of clone 34βE12 and α-methylacyl-CoA racemase for suspected prostate cancer: firstly, specifies the micromorphological picture and demasks prostate cancer; secondly, it increases the detectability of prostate cancer; thirdly, it reduces the occurrence of false-negative results.
first_indexed 2024-04-10T01:26:13Z
format Article
id doaj.art-997183da92314201b6c8e9ef53cc9e6e
institution Directory Open Access Journal
issn 2410-1893
language Russian
last_indexed 2024-04-10T01:26:13Z
publishDate 2019-04-01
publisher QUASAR, LLC
record_format Article
series Issledovaniâ i Praktika v Medicine
spelling doaj.art-997183da92314201b6c8e9ef53cc9e6e2023-03-13T09:35:00ZrusQUASAR, LLCIssledovaniâ i Praktika v Medicine2410-18932019-04-0161414910.17709/2409-2231-2019-6-1-4245IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSYS. V. Popov0R. G. Guseynov1O. N. Skryabin2I. N. Orlov3A. A. Vorobyov4A. G. Martov5V. L. Shchukin6СП ГБУЗ «Клиническая больница Святителя Луки» Комитета по здравоохранению Правительства Санкт-ПетербургаСП ГБУЗ «Клиническая больница Святителя Луки» Комитета по здравоохранению Правительства Санкт-ПетербургаСП ГБУЗ «Клиническая больница Святителя Луки» Комитета по здравоохранению Правительства Санкт-ПетербургаСП ГБУЗ «Клиническая больница Святителя Луки» Комитета по здравоохранению Правительства Санкт-ПетербургаСП ГБУЗ «Клиническая больница Святителя Луки» Комитета по здравоохранению Правительства Санкт-ПетербургаФГБУ «Государственный научный центр – Федеральный медицинский биофизический центр им. А.И.Бурназяна»СП ГБУЗ «Городская больница №20» Комитета по здравоохранению Правительства Санкт-ПетербургаMorphological manifestations of prostate cancer (PCa) in 15–20% of cases are similar to those with benign hyperplastic processes in prostate tissue and/or with a histological pattern of atypical small acinar proliferation (ASAP).The purpose of this study is a comparative study of the detection of prostate cancer in biopsy material using a review morphological analysis and immunohistochemistry with the use of monoclonal antibodies to the nuclear p63 protein, high molecular weight cytokeratins of clone 34βE12 and α-methylacyl-CoA-racemase.Materials and methods. The method of the study was a retrospective analysis of the findings on the review morpholog­ical and immunohistochemical (IHC) analyzes of biopsy material of 428 patients who were examined and treated in the urological hospital for the period from 2013 to 2017.Results. Almost half of the cases of ASAP, determined by routine histological examination of biopsy specimens with hematoxylin-eosin staining, in the process of IHC analysis using monoclonal antibodies to the nuclear protein p63, cyto­keratins of clone 34βE12 and α-methylacyl-CoA racemase were verified for prostate cancer. The number of histological findings on benign prostatic hyperplasia detected in routinely stained preparations decreased by 12.38% in favor of the histological diagnosis of prostate cancer after the IHC study.Conclusion. Immunohistochemical analysis of biopsy material using monoclonal antibodies to nuclear p63, high-molec­ular cytokeratins of clone 34βE12 and α-methylacyl-CoA racemase for suspected prostate cancer: firstly, specifies the micromorphological picture and demasks prostate cancer; secondly, it increases the detectability of prostate cancer; thirdly, it reduces the occurrence of false-negative results.https://www.rpmj.ru/rpmj/article/view/356рак предстательной железыатипичная мелкоацинарная пролиферацияиммуногистохимический анализвысокомолекулярный цитокератин 34βe12ядерный белок р63α-метилацил-коа-рацемаза
spellingShingle S. V. Popov
R. G. Guseynov
O. N. Skryabin
I. N. Orlov
A. A. Vorobyov
A. G. Martov
V. L. Shchukin
IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY
Issledovaniâ i Praktika v Medicine
рак предстательной железы
атипичная мелкоацинарная пролиферация
иммуногистохимический анализ
высокомолекулярный цитокератин 34βe12
ядерный белок р63
α-метилацил-коа-рацемаза
title IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY
title_full IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY
title_fullStr IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY
title_full_unstemmed IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY
title_short IMMUNOHISTOCHEMICAL ANALYSIS AS A METHOD FOR INCREASING THE DETECTION OF PROSTATE CANCER IN PRIMARY BIOPSY
title_sort immunohistochemical analysis as a method for increasing the detection of prostate cancer in primary biopsy
topic рак предстательной железы
атипичная мелкоацинарная пролиферация
иммуногистохимический анализ
высокомолекулярный цитокератин 34βe12
ядерный белок р63
α-метилацил-коа-рацемаза
url https://www.rpmj.ru/rpmj/article/view/356
work_keys_str_mv AT svpopov immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy
AT rgguseynov immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy
AT onskryabin immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy
AT inorlov immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy
AT aavorobyov immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy
AT agmartov immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy
AT vlshchukin immunohistochemicalanalysisasamethodforincreasingthedetectionofprostatecancerinprimarybiopsy